Monitoring BBC open interest helps you see where real money is positioned on Virtus Biotech Clinical Trials ETF's options and which strikes are attracting the most commitment from traders. Virtus Biotech Clinical Trials ETF's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor BBC options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising BBC options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Virtus Biotech Clinical Trials ETF to settle.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where BBC open interest is concentrated. Our scanner maps Virtus Biotech Clinical Trials ETF's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Virtus Biotech Clinical Trials ETF's options open interest as the signal it is, not as an afterthought.
